News
SCYNEXIS Q4 EPS $(0.39) Misses $(0.20) Estimate, Sales $5.80M Beat $1.37M Estimate
28 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
SCYNEXIS Presented Preclinical Data On Second Generation Fungerp SCY-247 Against Mucormycosis At 11th Advances Against Aspergillosis and Mucormycosis Conference
29 Jan 24
Biotech, News, General
Press releases
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
9 Apr 24
News, Press Releases
SCYNEXIS to Participate in Guggenheim's 6th Annual Biotechnology Conference
30 Jan 24
News, Press Releases
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference
29 Jan 24
Press Releases, General